Trial Profile
Combination of lamivudine and adefovir dipivoxil for treatment of chronic hepatitis B.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Adefovir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 03 Apr 2013 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 18 May 2010 Planned end date changed from 1 Sep 2006 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual patient number (41) added as reported by ClinicalTrials.gov.